Organizing Committee
Harley Eisman, MD, Chair
Co-Founder, Hereditary Breast and Ovarian
Cancer Foundation, Montréal, QC, Canada
William Foulkes, MBBS, PhD, Scientific Programme Director
Director, Program in Cancer Genetics,
McGill University, Montréal, QC, Canada
Laura Hayes, Public Conference Programme Director
McGill University, Montréal, QC, Canada
Scientific Programme Committee
William Foulkes, MBBS, PhD
Director, Program in Cancer Genetics,
McGill University, Montréal, QC, Canada (Chair)
Lawrence Brody, PhD
National Human Genome Research Institute,
National Institutes of Health, Bethesda, MD, USA
Tuya Pal, MD
Vanderbilt - Ingram Cancer Center, Nashville, TN, USA
Laura Palma, MSc, CGC, CCGC
McGill University Health Centre, Montréal, QC, Canada
Mark Robson, MD
Memorial Sloan-Kettering Cancer Center,
New York, NY, USA
Marc Tischkowitz, MD, PhD
University of Cambridge, Cambridge, UK
Clare Turnbull, MD, PhD, MFPH
Institute of Cancer Research, London, UK
Abstract Review Committee:
Patricia N. Tonin, PhD
The Research Institute of the MUHC,
Montréal, QC, Canada (Chair)
Blaise Clarke, MD
University Health Network, Toronto, ON, Canada
Lesa Dawson, MD
University of British Columbia, Vancouver, BC, Canada
Yann Joly, PhD
McGill University, Montréal, QC, Canada
Raymond Kim, MD, PhD
Princess Margaret Cancer Centre, Toronto, ON, Canada
Jeanna McCuaig, PhD
Princess Margaret Cancer Centre, Toronto, ON, Canada
Kelly Metcalfe, RN, PhD
Women's College Research Institute, Toronto, ON, Canada
Marjanka Schmidt, PhD
Netherlands Cancer Institute, Amsterdam, and Leiden University Medical Center, Leiden, The Netherlands
Kasmintan (Intan) Schrader, MBBS, PhD
BC Cancer, Vancouver, BC, Canada
Britta Weigelt, PhD
Memorial Sloan-Kettering Cancer Center, New York, NY, USA
PHOTO: Mary Queen of the World Cathedral / Skyline of downtown Montréal. © Tourisme Montréal